On February 10, 2022 Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders, reported that the Company’s leadership will participate in the following virtual conferences (Press release, Orum Therapeutics, FEB 10, 2022, View Source [SID1234607957]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

● SVB Leerink 11th Annual Global Healthcare Conference – February 14th – 18th, company leadership will be available for meetings

● BMO Biopharma Spotlight Series: Protein – Degraders and Other Next Gen Technologies – February 24th at 10:10am ET, Panel Discussion and Q&A, "Next Gen Therapies – Fighting For "De Grader" Good